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Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 7 
 
 
 
 
© 2013 Foyaca Sibat and de Fátima Ibañez Valdés, licensee InTech. This is an open access chapter 
distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited. 
What is a Low Frequency of the Disseminated 
Cysticercosis Suggests that Neurocysticercosis  
is Going to Disappear? 
Humberto Foyaca Sibat and Lourdes de Fátima Ibañez Valdés  
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/51395 
1. Introduction 
The zoonotic infections that affect the man can be caused by viruses (rabies, avian influenza, 
immunodeficiency virus from apes [VIS]), bacteria (brucellosis, salmonellosis), parasites 
(leishmaniasis and schistosomiasis, neurocysticercosis, toxocariasis) and other non-
conventional agents such as prions (bovine spongiform encephalopathy and a variant of 
Jakob-Creutzfeldt disease) on which enough has been written[1]. 
There are 1407 pathogens that affect humans (excluding the ectoparasites), more than half 
(816) are zoonotic and 73% (130) cause zoonotic diseases that affect community health [2]. 
Parasitic diseases have occurred through the times more deaths and economic damage to 
humanity that all the genocidal wars together. Parasitic infections previously seen only in 
developing tropical settings can be currently diagnosed worldwide due to travel and 
population migration. Generally in countries with little socio-economic development is 
where parasitic diseases are presented with greater frequency, still this is offered by climatic 
conditions warm or temperate zone and by the lack of education for health in the 
population; because in the developed countries social, medical and economically, parasitic 
diseases have been eradicated or have very little significance [3]. 
Neurocysticercosis (NCC) is the parasitic disease more frequent of the CNS and the causal 
agent of the same is the larval stage of the T solium cysticerci when invades brain of a 
human being that has swallowed the viable eggs from food or contaminated liquids, from a 
carrier, by infection secondary to a reverse peristalsis or by the well-known fecal-oral route 
[4-6]. The man is in turn the only known host for the adult form of the parasite. This disease 
is a serious health problem for many third-world countries of Asia, Africa, and Latin 
America; moreover, a growing number of cases are being reported in many highly 
developed countries in Europe and North America, notwithstanding the foregoing, the 
 Novel Aspects on Cysticercosis and Neurocysticercosis 162 
incidence and prevalence accurate of this disease have not been confirmed from well-
designed studies. Disseminated cysticercosis (DCC) was reported in 1912 by doctors of the 
English Navy stationed in India. Priest in 1926, describes a British soldier patient presenting 
an inflammation of the skeletal muscles, seizures, mental dulling and a large amount of 
subcutaneous nodules distributed throughout the body [7]. An intensive search performed 
in 1988 revealed 22 cases [7] and only 16 additional cases were reported until 2006 reported 
in the international medical literature most of them from India. [8]. It is considered that 
cysticercosis (CC) is a major problem for public health in several developing countries 
where the social, economic and cultural conditions favor the maintenance of this zoonotic 
disease and it is seen as a growing community problem in those developed countries with a 
high rate of immigrants from endemic areas. WHO includes the NCC between neglected 
diseases that cause a significant impact on the economy in several regions of the world. It 
affects 4% of the population in endemic areas [4, 9] and is the main cause of symptomatic 
epilepsy worldwide [1, 10-15] but where the hygiene habits-food and sometimes religious 
trends can determine the incidence and prevalence of the disease [1]. 
Based in our experience and according to this review of the literature we can say that in 
regions where the CC is endemic, the presence of late onset seizures in subjects older than 25 
years of age is highly suggestive of NCC what had already been established since 1982 [16]. 
In the published series, the age group most commonly affected by the NCC, is the group of 
35 to 63 years [18-20]. The males are most affected than females in the majority of the studios 
[17-19]. In 2003, Mafojane [20] reported a high prevalence in children and young South 
Africans in a region where the CC virtually does not exist. 
Probably, there is a progressive decrease incidence of DCC based in our local perception 
and disseminated cysticercosis is always associated with NCC but it does not mean that the 
NCC is on the way to disappear completely in the next decade. In this chapter we will 
present a bibliographic investigation on the DCC, its prevalence in our region, and our 
arguments on the because we are going to spend many years before that the DCC eradicated 
from the face of the earth. 
The pathogenesis and clinical manifestations of CC depend on the number, size, location, 
evolutionary state of the parasite and the host’s immune response [1,5,10-15, 21-23]. In the 
above-mentioned studies, appear only the seizures and the headache as initial clinical 
manifestations while in others it is reported: meningitis, dementia, intracranial 
Hypertension, psychiatric symptoms, ischemic stroke, and radicular compression [10-15,17, 
24-30]. It is important to note that the headache is not the most frequent clinical 
manifestation of the NCC in the majority of published studies but that occupies the second 
place; only in one of the studies consulted is presented as the main reason for consultation 
[19]. In the majority of the series, the frequency of headache varies from 4.6 % to 61.5 % 
[19,23-24]. While the frequency of seizures as a form of presentation of the NCC ranges from 
54.3 % to 62.5 % in general series [12, 23, 27, 31-34]. In children the frequency of seizures to 
be the initial manifestation is higher, ranging from 72% to 94.8 % according to other authors 
[29, 35]. In summary, the majority of published studies confirm that the epilepsy and 
headache were the most frequent clinical manifestations of the NCC [1,10-15, 17, 24, 27-30, 
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36]. These manifestations begin between one and 35 years after the exposure to the parasite, 
as demonstrated in patients from the British army stationed in India where it is defined exactly 
the time of exposure to the parasite and the onset of clinical manifestations. The average life 
Expectancy of the parasite is estimated to be between four and five years [37]. The epilepsy 
secondary to NCC (ESNCC) responds well to first line antiepileptic drugs (AED) [1,10-15, 
19,24, 28,31, 33, 38]. Other AED as the levetiracitam has also shown good results, but its high 
cost and lack of availability in the public sector and the primary health care system make it 
considered without practical usefulness for the control of the ESNCC [1]. Patients with DCC 
can present: refractory epilepsy, neuropsychiatric disturbances, pseudo hypertrophy in the 
four limbs and affectation of any other organ or system [8]. However, a fairly typical 
manifestation of the DCC is the subcutaneous cyst that occurs as a asymptomatic nodule. 
These subcutaneous nodules can be slide easily in the muscle tissue and measure up to 1.5 cm 
in diameter. In the case of patients who have suffered from the disease for more than five 
years, usually these are calcified [39]. 
Recently, Bielsa-Fernández [40] reported a patient carrier of severe rheumatic polymyalgia 
of the trunk and limbs with serological surveys negative for the CC and two muscle biopsy 
confirmed encapsulated nodules with diffuse calcification, compatible with parasitic 
diseases, whose state of calcification prevented identify the characteristics of the parasite. 
Logically, the presence of active NCC leaves no doubt about the nature of the subcutaneous 
nodules and reinforces the importance of bearing in mind the diagnostic criteria of Del 
Brutto for the correct differential diagnosis [41]. 
The main characteristic the DCC is structural epilepsy due to neurocysticercosis  and the 
pseudo-hypertrophy in the four members and the allocation of any other organ or system 
[8]. However, a manifestation fairly typical of the DCC may be subcutaneous cyst that 
occurs as a nodule asymptomatic. These subcutaneous nodules can be sliders in the muscle 
and measure up to 1.5 cm. In the case of patients who have had for more than 5 years 
cysticerci, these are calcified [39]. A few months ago, Bielsa-Fernández [40] reported a 
female patient with a severe rheumatic polymyalgia of the trunk and limbs with serological 
studies for the CC negative and two muscle biopsy confirmed two nodes encapsulated with 
diffuse calcification, compatible with parasitosis, whose calcification of the content made it 
difficult determine the type of parasite. Logically, the presence of NCC active leaves no 
doubt about the nature of the subcutaneous nodules. 
The pharmacological treatment of DCC reported good results for some patients with 
subcutaneous and muscular involvement if the CNS is not severely affected [41, 42]. On the 
other hand, have been confirmed cases with DCC and chronic liver disease in which case 
even if the ELISA test was suggestive, the final diagnosis was obtained by CT scans of the 
brain [43], and have been reported cases with unilateral eye lesion [44], and even bilaterally 
[80], thyroid involvement [8, 45] , pancreatic enzyme alterations [46] or without clinical or 
biochemical alterations of pancreatic function [47], spleen damage [47,47], cardiac [8, 48-53], 
even without associated DCC [52], lung [45, 53-55], joints [56] and  muscles of the face and 
neck [44, 48]. There is not reported cases of DCC without involvement of CNS and its 
frequency may be the expression of an increase or decrease in the overall prevalence of 
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porcine cysticercosis in general [1]. The host inflammatory response depends on the 
parasite’s ability to evade host immunity. Usually both ‘healthy’ (active) and ‘involuted’ 
(inactive) cysticerci lack inflammatory response, which is restricted to ‘currently 
degenerating’ cysts whose ability to evade host defenses is becoming faulty. Involution of 
cysts implies granulomatous inflammation [56].  
Epilepsy is the most common neurological manifestation of DCC in our region and it has 
been well documented in previous publication. [41,50] However seizures disorder in HIV 
patients present special problem with regard to choice of antiepileptic drugs (AED) and the 
potential for drug-drug interactions with antiretroviral (ARV) treatments also in our region. 
Newer AEDs with simpler pharmacokinetic profiles may be the preferred agents, 
particularly when protease inhibitors form part of ARV regimens. Seizures in NCC are 
easily controlled with the first line AEDs. Although there has been some debate about the 
value of anti-parasitic drugs in NCC, accumulating data suggest that the use of these agents 
in active disease decreases the risk for development of chronic epilepsy [57].  
2. Methodology 
In this chapter we included only cases reported to the medical literature, therefore no major 
ethical problems are afforded. Nevertheless, in order to protect all subjects participating in 
our studies, as part of a general measure aimed at protecting patients selected it was agreed 
that the principal investigator (HFS) and collaborators (LdeFIV) should adopt a program of 
basic training on the protection of human beings and animals participating in research 
studies and obtain the corresponding certificate which was done. All protocols were 
approved by the Review Committee from the University of Transkei and the Walter Sisulu 
University plus their respective Committee on Medical Ethics and the numbers of references 
are the following: Mthatha Hospital (UGH: 0001/99, letter of approval by the Director of 
Medical Services), University of Transkei (UNITRA:0018/05), and Walter Sisulu University 
(IRB) and their respective Ethics Committee (WSU:0068/09). The model of informed consent 
was signed by all participants in the first contact as a prerequisite to participate. To illiterate 
patients were explained the objectives of the study, the procedures which were to be 
subjected and their risks and the model of consent was signed by a family member, relative 
or a witness. To all patients we explained their rights to participate or not, with the 
assurance that in any case, this would not cause change in management or the attention of 
the same or other rights of any patient, their rights on anonymity (personal data replaced by 
keys), and to keep any information in strict confidentiality. In this chapter we did not use 
any graphical or written confidential information from patients reported by other author. 
3. Results 
3.1. Disseminated cysticercosis in South Africa 
The former Transkei is the poorest region in South Africa and it was a well known batustan 
during the apartheid régimen before 1994. To the population of Xhosa origin were assigned 
the regions of the Ciskei and Transkei and Transkei is termed as an independent state in 
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1974 but was only recognized by South Africa with whom confronted territorial disputes 
between 1974 and 1978. The natural history of the NCC must be viewed within the historical 
context of this region in order to understand why the NCC has been confined almost to the 
former Transkei (currently region C and D of Eastern Cape Province), still the only endemic 
area of the country from where they come from all the sick people who could be diagnosed 
in the rest of the country. 
Human cysticercosis appears to be most prevalent in Eastern Cape Province particularly in 
the poor, former black homeland, rural areas of Transkei, where pigs are allowed to roam 
freely and sanitation facilities are inadequate or nonexistent. Pig keeping and pork 
consumption have increased significantly during the past decade especially in rural 
smallholder communities, primarily due to the lack of grazing land for ruminants and the 
recognition of farmers of a quicker and more impressive return on their investment from 
raising pigs.  
The first inform about patients presenting DCC in South Africa was made by Schultz and 
Mentis [58] In 1987. They reported a 48-year-old black man with two month history of a 
painless mass on the left side of his neck. He also complained of mild attacks of paroxysmal 
dyspnoea at night and progressive deafness of his left ear. On direct questioning the patient 
referred few grand mal seizures during the 6 years before admission. No other complaints 
or previous illnesses of note were elicited. The patient was born in Transkei (near to 
Mthatha) and had travelled throughout many parts of the country seeking work. On 
examination he appeared healthy and was of normal build. The pulse rate was 72/min, 
blood pressure 110/60 mmHg and temperature 37,2°C. Numerous subcutaneous nodules, 
ranging from one to three centimeter in diameter, which were well circumscribed and freely 
movable, could be palpated all over the neck, chest and legs. A bigger mass was palpable 
inferior to the left ear, extending down the left side of the neck. There was conduction 
deafness of the left ear. On chest auscultation a few fine crepitations were audible at the 
bases of both lungs, chest radiography revealed multiple nodular opacities; computed 
tomography of the brain, neck, thorax and upper abdomen revealed extensive organ 
involvement, including brain, thyroid, lungs, pancreas, kidney, spleen and muscle; and 
biopsies of two of the subcutaneous nodules were histologically pathognomonic of 
cysticercosis. The patient received praziquantel (Biltricide; Bayer-Miles) 1, 75 g twice daily 
and prednisone 20 mg per day for 4 weeks. He was reassessed radiologically after 4 weeks. 
There was marked regression in the size and numbers of nodules in the lung fields. 
Clinically, most of the subcutaneous nodules had disappeared. This is the only report in the 
international medical literary on CCD with so large involvement of organs and systems 
including the kidneys. 
Bhigjee in 1999 [59], reported the second patient presenting DCC in South Africa. His patient 
was an Indian male presenting generalized subcutaneous and muscular nodules and 
neurocysticercosis. Diagnosis was confirmed by plain X-rays of the soft tissues in upper and 
lower limbs and CT scan of the brain where multiple bilateral active and calcify cysticerci on 
both cerebral hemisphere were found. (Figure 1) 
 Novel Aspects on Cysticercosis and Neurocysticercosis 166 
 
Figure 1. Shows generalized subcutaneous and intramuscular calcified nodules on lower limbs and 
intraparenchymal neurocysticercosis in vesicular, colloid and calcified stages. (Source: J Neurol 
Neurosurg Psychiatry 1999; 66(4): 545. Bhigjee A). 
Five years later we reported a 42-year-old man (third report) admitted at Nelson Mandela 
Academic Hospital Mthatha in South Africa. He presented a history of recurrent generalized 
tonic-clonic epileptic seizures of six years duration, disseminated nodules all over the body 
of two-year duration and headache. On general examination multiple subcutaneous and 
intramuscularly, mobile, no tender nodules, measuring from 0.7 to 2.5 cm, were palpable on 
the chest, back, abdomen, and proximal regions of the four limbs. (Figure 2-3-4) Respiratory 
and cardiovascular system were normal except for a bradycardia of 42 bpm. A computed 
tomography (CT) scan of the brain showed multiple active and calcified lesions. Biopsy of 
the subcutaneous nodules confirmed the diagnosis of cysticercosis (Figure 3). A detailed 
neurological examination revealed unremarkable findings. Laboratory data were normal, 
ELISA test and IgG for cysticercosis were strongly positive. ECG and cardiac ultrasound 
confirmed: sinus bradicardia, II grade heart block, and calcifications in papillary muscles 
and upper septum respectively. CT Scan of the brain (Figure 4) shows bilateral cysts in 
different active stages and calcified NCC. [41] 
We referred this patient to the cardiology clinic in our hospital for assessment of 
bradycardia and some findings were reported later by other authors [60]. Patient felt dizzy 
on getting up suddenly from a supine position. His pulse rate was 41/min, irregular and his 
blood pressure 76/124 mmHg. An electrocardiogram (ECG) showed sinus bradycardia with 
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complete heart block (Figure 5). The patient was initially treated only with prednisolone, 
and anti-helminthic treatment was deferred fearing peri-cystic inflammation and 
aggravation of the conduction abnormalities. Five days later praziquantel 50 mg/kg/day for 
14 days were added to the treatment regimen. Repeat ECG after a week of treatment 
showed sinus rhythm with a heart rate of 70/min. Diagnostic criteria for disseminated 
cysticercosis for this patient is based on the presence of NCC, subcutaneous, and muscular 
cysticercosis simultaneously. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Multiple subcutaneous nodules on the chest wall and a few calcified lesions on chest X-ray. 
(Photo taken by H Foyaca-Sibat. Source: Foyaca et al., Rev Electron Biomed / Electron J Biomed 
2004;3:39-43. Written patient consent is obtained). 
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Figure 3. Multiple calcified subcutaneous and paravertebral nodules. (Photo taken by H Foyaca-Sibat. 
Source: Foyaca et al., Rev Electron Biomed / Electron J Biomed 2004;3:39-43. Patient written consent is 
obtained). 
 
Figure 4. CT scan of the brain showing multiples intraparenchymal cysticerci in vesicular, colloid and 
calcified stages. 
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Figure 5. shows sinus bradycardia with complete heart block.[60]  
The principal electrocardiographic (ECG) alterations are first-degree atrioventricular (AV) 
block, low QRS (QRS interval of the ECG) voltage, and primary T-wave changes (as can  
seen in Chagas’ disease).  
 
Figure 6. CT scan of chest confirmed the presence of cysts within the myocardium.[60] 
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In 2007, we reported a 48-year-old African male patient (Fouth patient) admitted at Nelson 
Mandela Academic Hospital in Mthatha, South Africa presenting a history of recurrent 
generalized tonic-clonic epileptic seizures with urinary incontinence of five years duration. 
Patient reported to have fitted at home with three episodes on the day of admission and 
sustained burns on the right leg while he was unconscious (Figure 7).  
 
Figure 7. Show a burning lesion acquired during tonic-clonic generalized epileptic seizure. (Photo 
taken by H Foyaca-Sibat. Source: H. Foyaca-Sibat & L. Ibanez-Valdes: Generalized Cysticercosis With 
Cardiac Involvement. The Internet Journal of Neurology. (ISSN: 1531-295X) 2007;  7(2):6-11. 
Burn is a frequent accident for epileptic peoples while they having epileptic seizures in rural 
areas when electricity is not available and they need to keep small fire inside the room as 
alternative way to survive during the winter. Unfortunately, there is not sustainable 
solution for this problem at the present moment. 
This patient was on oral carbamazepine 200mg three times a day, but he discontinued 
treatment 2 weeks back because medication was not available at the nearest medical clinic. 
On general examination multiple subcutaneous and intramuscularly, mobile, no tender 
nodules, measuring from 0.7 to 2.5 cm, were palpable on the chest, back, abdomen, proximal 
regions of the four limbs and hemi-face (Figure 8-12). Respiratory and cardiovascular 
system were normal except for a bradicardia of 46 beat per minute. A detailed neurological 
examination revealed unremarkable findings. Laboratory data included routine blood test 
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(FBC, U&E, glucose, urinalysis) were normal, erythrocyte sedimentation rate and cardiac 
enzymes were also normal. ELISA test and IgG for cysticercosis were strongly positive.  
Plain chest X-rays and X-rays of long bones showed multiple “cigar-shape calcifications” 
(Figure 11) and abdomen ultrasound confirmed multiple subcutaneous cystic lesions seen 
with centric enhancing form remembering the typical “dot-in-hole”. ECG and cardiac 
ultrasound confirmed: sinus bradicardia, II grade heart block and calcifications in papillary 
muscles and upper septum respectively (Figure 7). CT scan of the brain showed bilateral 
cystic lesions in vesicular and colloid stages, and calcified NCC [50]. Plain X-ray studies of 
the muscles are also useful to identify the typical “cigar-shape” calcifications on the 
subcutaneous tissue, and if any query arise then a positive serological test for T solium 
(antigen/antibody) will help while the final diagnosis is confirmed by biopsy of the 
subcutaneous nodules or confirming NCC by imagenology. 
 
 
 
 
 
 
Figure 8. Show subcutaneous nodule on the right lateral aspect of the neck and multiple subcutaneous 
nodules in the upper back mainly on the right side. (Photo taken by H Foyaca-Sibat. Source: H. Foyaca-
Sibat & L. Ibanez-Valdes: Generalized Cysticercosis With Cardiac Involvement. The Internet Journal of 
Neurology. 2007 Volume 7 Number 2.) 
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Figure 9. Shows multiple subcutaneous nodules in the left arm some of them were located in the biceps 
brachialis. (Photo taken by H Foyaca-Sibat. Source: H. Foyaca-Sibat & L. Ibanez-Valdes: Generalized 
Cysticercosis With Cardiac Involvement. The Internet Journal of Neurology. 2007 Volume 7 Number 2.) 
 
Figure 10. Shows a nodular lesion in the left hemiface at the zigomatic arch level removed by surgical 
procedure and histological examination confirmed subcutaneous cysticercosis (Photo taken by H 
Foyaca-Sibat. Source: H. Foyaca-Sibat & L. Ibanez-Valdes: Generalized Cysticercosis With Cardiac 
Involvement. The Internet Journal of Neurology. 2007 Volume 7 Number 2. Patient written consent is 
obtained) 
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Figure 11. Plain X-ray of the chest and upper limbs show multiple subcutaneous and intramuscular 
“cigar-shape” calcifications.  
 
Figure 12. Cardiac ultrasound shows cysticercus in the cardiac muscle. 
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Ultrasography to diagnose subcutaneous cysticercosis was introduced a few years ago and 
from the beginning we also found some limitations to differentiated cysticercosis from 
lymphadenopathies, neurofibromas, and epidermoid cysts [41] however at the present 
moment is possible to confirm a diagnosis for subcutaneous nodules showing the scolex 
inside. Echocardiogram has a hight level of accuracy in cardiocysticercosis and we could 
confirm it in patients.  
All South African patients presenting CCD also suffrering of symptomatic epilepsy because 
all had cerebro-cortical lesions caused by T. solium.  
4. Disseminated cysticercosis and epilepsy 
Epilepsy is also the most common clinical manifestation of NCC in our region [61-64] and it 
prevalence has been well documented in several communities of Eastern Cape Province in 
South Africa. [65-71]. While disseminated cysticercosis is an exceptional expression of CC 
characterized by high morbidity due to massive symptomatic parasite burden in the central 
nervous system, striated muscles, subcutaneous tissues and other organs. Less than 50 such 
cases have been reported worldwide and fewer than 10 children. In 2010, Kumar and 
collaborators [72] reported their findings on whole-body MRI as a diagnostic tool for 
extensively disseminated cysticercosis in a child and highlighted its role in diagnosis and 
management of this pleomorphic disease. Unfortunately, MRI is not available for most of 
patients with CCD worldwide and it can not replace the traditional way of diagnosis based 
on CT scan of the brain for NCC and plain X-ray for muscular and subcutaneous 
cysticercosis. Diagnosis of NCC can be made by Del Brutto’s recommendation [73] but novel 
criterias suggested by Carpio in this boork, should be considerd  
5. The disseminated cysticercosis going to disappear in the near future? 
Before moving to another topic we would like to answer that research question. 
We are convinced that CC will be eradicated from our planet, but today this is far from 
happen especially in some countries of Sub-Saharan Africa, Asia and Latin America, where 
there are communities who live, or have lived, either by choice (peoples living in voluntary 
isolation) or by circumstance, without significant contact with globalized civilization, 
therefore their current epidemiological situation is unknown and we even don’t know how 
many peoples are infected by parasites. 
We know that T. solium infested man long before there was any evidence of animal 
domestication (See chapter 1) [74, 75] by which we can assume that even in communities 
where very backward the taming of animals there is no zoonotic diseases may be acquired 
by other means. 
For the other hand, there is an important number of hidden groups of peoples such as: racist 
groups and racist activists; drug traffickers in prisons; natives from the Central African Rain 
Forest; male and female prisoners and guards from a number of prison colonies; nationalists 
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expressing anti-Semitic sentiment and young people participating in radical social and 
political mobilization among others [76]. How many of these hidden groups suffer of T. 
solium cysticercosis? We do not know.  
In our opinion, even when the poverty disappear from underdeveloped countries and every 
person get a proper access to clean and safe water, living in very good hygienic conditions 
under an ideal health education and primary health care sustainable system program, we 
could not proclaim that the CC has been eradicated because of that important number of 
human beings sharing our planet whose epidemiological situation remain unknown. We are 
aware about an important number of individuals that still remains in that situation.  
Congo region is included in our Cysticercosis Working Group for Eastern and Southern 
Africa (CGWESA). The Bambuti are pygmy hunter-gatherers, and are one of the oldest 
indigenous people of the Congo region of Africa. They are composed by bands which are 
relatively small in size, ranging from 15 to 60 people. The Bambuti population totals about 
30,000 to 40,000 people. The forest where they live is a moist, humid region strewn with 
rivers and lakes. Disease is prevalent in the forests and can spread quickly, killing not only 
humans, but plants, and animals, the major source of food, as well. Their animal foodstuffs 
include crabs, shellfish, ants, larvae, snails, pigs, antelopes, monkeys, fishes, and honey. The 
vegetable component of their diet includes wild yams, berries, fruits, roots, leaves, and cola 
nuts [77]. Anyone is infected by T. solium?, Who knows? We do not know. 
Many parts of the Americas are still populated by indigenous Americans; some countries 
have sizable populations, especially Bolivia, Peru, Mexico, Guatemala, Colombia, and 
Ecuador. Some indigenous peoples still live in relative isolation from Western society, and a 
few are still counted as uncontacted peoples [78]. Most uncontacted communities are located 
in densely forested areas in South America and New Guinea. Knowledge of the existence of 
these groups comes mostly from infrequent and sometimes violent encounters with 
neighboring tribes, and from aerial footage. Isolated tribes may lack immunity to common 
diseases, which can kill 50 to 80 per cent of their people after contact [79] but nobody knows 
how many parasites are affecting them. 
The Sentinelese continues to actively and violently reject contact. They live on North 
Sentinel Island, a small and remote island which lies to the west of the southern part of 
South Andaman Island. They are thus considered the most isolated people in the world, and 
they are likely to remain so [73]. The current epidemiological situation on parasitic zoonoses 
of Sentinel is still unknown. 
In Paraguay remains perhaps as many as 300 Totobiegosode who have not been contacted; 
they belong to the Ayoreo ethnicity, which numbers around 2,000. As of 2006, the presence 
of five uncontacted groups was confirmed in Bolivia; three more uncontacted groups are 
believed to exist. On January 18, 2007, the National Indian Foundation reported that it had 
confirmed the presence of 67 uncontacted tribes in Brazil, up from 40 in 2005. With this 
reported increase, Brazil has surpassed the island of New Guinea as the region having the 
highest number of uncontacted tribes. Ecuador continues to be the country with the largest 
number of uncontacted people killed since 2000. After Brazil and New Guinea (Papua New 
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Guinea and Iriyan Jaya), Peru has the largest number of uncontacted tribes in the world [79] 
and there is not available information about their current situation related to incidence or 
prevalence of infectious diseases. 
Today there are more than 150 million tribal peoples worldwide, including at least 70 
uncontacted tribes, living in 60 countries. Some organization such as: Survival International 
supports these endangered tribes on a global level, with campaigns established in America, 
Africa and Asia [80, 81]. In our opinion, many of them can be parasitized by T. solium as was 
the H ergatus more than a million of the year ago (See chapter 1). 
Due to globalization, a growing number of uncontrolled immigrants from an endemic area 
in Latin America come to the USA every day, significantly increasing the number of cases of 
NCC in the country especially in Texas and California [82-91] where a total of 1494 patients 
with NCC were confirmed between 1980 and 2004 of which 66% suffered from epilepsy, 
16% had a obstructive hydrocephalus and the 15% headache due to intraparechymal NCC 
(91 % ), intraventricular (6 %) or subarachnoid (2 %) either because travelled to endemic 
areas, were of Hispanic origin or had any contact with carriers of the parasite [92-93]. In 
Latin America has been described the existence of NCC in 18 countries with an estimated 
350,000 patients infected by the complex CC/TE. In 2008, Pawlowski stipulated that in the 
world would have approximately 2.5 million people infected T solium and at least 20 
million with CC [70]. 
Disseminate presentations of cysticercosis is not common in our region, only six patients 
were previously confirmed and four of them reported to the medical literature [41, 50, 58, 
59]. Typical manifestation is subcutaneous cyst present as nodules that tend to be 
asymptomatic [41, 50]. The natural history of the infection remains unknown up to date. 
However, is well known that most cysticercus complete their development within two to 
four months after larval entry living there months to years, and their locations in order of 
frequency are the central nervous system, subcutaneous tissues, striated muscle, heart, 
orbits, and other tissues. Human cysticercosis is acquired after eating food contaminated 
with fertilized eggs excreted in the feces of Taenia’s carriers. In humans the most common 
routes of infection (cysticercosis) are ingestion of T .solium eggs from contamined food and 
fecal-oral auto-infestation in patients harbouring the adult parasite in their intestines. While 
the cysts can develop in most human tissue, they have a predilection for CNS. Cysticercosis 
is estimated to affect approximately 50 million people worldwide and is common in rural 
South Africa [1, 10-15, 61-71].  
6. Disseminated cysticercosis with involvement of other organs 
6.1. Cardiocysticercosis 
The vast majority of patients with DCC reported to international medical literature are from 
India and although CC can affect almost any tissue the most frequently reported are the 
central nervous system and skeletal muscles [41,50,58]. Myocardial cysticercosis is rare 
[94,95] but its diagnosis is easier with modern radiological tools [95-97] . We will see in more 
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detail the most important features of the cysticercosis of the cardiac muscle followed by 
cysticercosis in the lungs and the combination of both presentations. 
As before-mentioned DCC means distribution of cysticerci along to the brain, skeletal 
muscles and subcutaneous tissues. In this part of the chapter we will discuss about other 
organs affected. 
Long before the emergence of computerized tomography knew each other from the first 
cases with cardiocysticercosis with other associated diseases of the heart in living patients 
[98], even with silent presentation [ 99] or disorders of cardiac conduction [100]. The lack of 
brain imaging studies did not confirm the presence of associated NCC in those cases. Spent 
10 years and then was possible achieve a better image of the heart and confirm best results 
with the use of praziquantel in this  type of presentation associated with  DCC [101]. Some 
parasites may directly or indirectly affect various anatomical structures of the heart, with 
infections manifested as myocarditis, pericarditis, pancarditis, or pulmonary hypertension. 
In other situations, parasitic infections may have more direct effects on various structures of 
the heart (myocardium, pericardium, endocardium, or the cardiac vasculature). The 
involvement of the myocardium may lead to myocarditis or different types of 
cardiomyopathies (i.e., dilated or restrictive). When the pericardium is affected, it may lead 
to pericarditis, pericardial effusion, cardiac tamponade, or constrictive pericarditis. Due to 
growing migration, population displacement, and travel, clinicians anywhere around the 
globe must be aware of the potential cardiac manifestations of parasitic diseases [57,102]. 
The myocardial inflammatory response is variable, resulting in granuloma formation and 
fibrosis, which subsequently leads to arrhythmias and conduction abnormalities either 
spontaneously or during treatment [57,103-105].  
Cardiac involvement in cysticercosis was thought to be rare, but autopsy studies have 
shown a prevalence of 20 to 25% in patients with concomitant documented 
neurocysticercosis [104,105]. Cardiac cysticercosis is often asymptomatic and discovered 
during cardiac surgery or at autopsy. Cysticerci are usually multiple and randomly 
distributed in cardiac tissues, including the subpericardium, subendocardium, and 
myocardium [104]. Rarely, a single cardiac cyst may be present [102]. The computed 
tomography and ultrasonographic studies have demonstrated a fundamental importance in 
the diagnosis of cysticercosis of the heart according with results reported by other authors 
[57,106-108] and own personal experience [41, 50]. 
The DCC also affects children severely, an example of that is in the five years old patient 
reported by Asrani [108] in 2004, who presented subcutaneous swellings all over her body. 
The swellings were each between 0.5 and 2 cm in size. There were only 1 or 2 to start with 
on the back of the neck, and then they gradually increased to involve the chest, head, neck, 
arms, and legs in 2 to 3 months. These swellings were accompanied by onset of abnormal 
behavior in the form of irritability, talkativeness, disobeying commands, and bladder 
incontinence (secondary enuresis). Also, there was abnormal weight gain of 10 kg. The 
patient also had decreased vision for one month. Examination revealed multiple 
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subcutaneous nodules between 0.5 and 2 cm in size over the forehead, abdomen, back, and 
legs. She weighed 29 kg (19 kg in a previous  month). Her vision was 6/30 according to the 
Snellen chart. The patient was referred for sonography of the abdomen. The abdominal 
visceras on examination with a 3.5-MHz convex transducer were unremarkable, but the 
abdominal wall showed some tiny cystic lesions. Further examination using a high-
frequency 7- to 12-MHz linear transducer (HDI 3000; Philips Medical Systems, Andover, 
MA) showed innumerable oval to circular, 0.5- to 1.5-cm, predominantly anechoic lesions in 
the subcutaneous tissues and abdominal wall muscles. Similar lesions were distributed over 
the back, neck, thighs, calves, legs, axillae, forearms, and arms. Sonography of the tongue 
also revealed similar multiple lesions. There was no increased vascularity surrounding these 
lesions on color Doppler examination. Only the palms and soles seemed to be uninvolved. A 
sonographic diagnosis of disseminated muscular cysticercosis was made. Whole-body 
contrast-enhanced computed tomography (CT) confirmed the sonographic findings and 
showed the classic “starry night” in the brain. The entire muscular system and the 
subcutaneous tissue had hypodense, nonenhancing, approximately 1-cm lesions without 
calcification, suggesting that all the cysts were live. Magnetic resonance imaging (MRI) of 
the brain,orbit, and musculoskeletal system showed multiple hyperintense lesions on 
transverse relaxation time (T2)-weighted images. 
A biopsy of the subcutaneous nodules showed classic cysts with a central scolex. Multiple 
ocular cysts were also found on ocular examination. After this, the patient started receiving 
steroids and anthelminthic agents. Within 4 weeks of starting treatment, the patient’s weight 
decreased by 10 kg  (to 19 kg again). She became quiet and began obeying commands. Her 
vision became 6/12 (Snellen chart). Echocardiography revealed extensive myocardial 
involvement. The major differential diagnosis is hydatid cyst, which is usually larger and 
multilocular. Antihelminthic treatment may result in pericystic inflammatory reaction 
which might worsen the clinical state [109].  
Other parasite can also affect the myocardium and the pericardium as we have previously 
pointed out, and that the most widely studied parasitic infection affecting the heart is 
Chagas' disease or American trypanosomiasis but African trypanosomiasis may also cause a 
myocarditis. The protozoan parasite, Entamoeba histolytica rarely causes a pericarditis 
while Toxoplasma gondii may cause myocarditis, usually in immunocompromised hosts. 
The larval forms of the tapeworms Echinococcus and T. solium may cause space occupying 
lesions of the heart. Severe infection with the nematode Trichinella spiralis may cause 
myocarditis [110]. 
Not always cardiocysticercosis is part of the disseminated cysticercosis as reported by 
Eberly and collaborators and it may occur as an isolated infection of the left ventricle [111]. 
In 2009, Shogan [112] reported a 17-year-old boy from Cameroon presenting a sessile cystic 
cardiac mass. A CT scan revealed a 1.0 × 1.5 cm nonenhancing, exophytic, ovoid mural-
based fluid density in the left ventricle along the endocardial surface of the anterior wall 
near the anteroseptal basal region. On T1-weighted MR images, the mass was hypointense. 
On T2-weighted MR images, the mass was hyperintense, with a rounded hypointense signal 
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visible at the posterior wall of the cyst. One internal septation of the mass was noted. After 
gadolinium administration, no enhancement was present. The patient underwent biopsy of 
the mass. Histologic evaluation showed a fluid-containing cystic structure, which exhibited 
a single protoscolex consistent with a cysticercus. These authors mentioned that 
involvement of the heart by T. solium is very rare and is usually diagnosed postmortem. 
After review the international medical literature we agree it is rare but diagnosis of 
cardiocysticercosis is made accurately in most of patient seeking for medical attention. 
Shogan’s report is extremelly uncommon because his patient had not an associated DCC or 
NCC [112], but without doubt the cardiocysticercosis must always be borne in mind in 
patients with similar presentations and because it is commonly associated with 
intraparenchymal NCC therefore to look for epilepsy is strong recommended. (See figure 13) 
 
Figure 13. Graphical representation of other affected organs and location of cysticerci in the CNS. 
6.2. Pulmonary cysticercosis  
Most of patients presenting pulmonary cysticercosis have multiple rather than solitary 
pulmonary nodules (a “spot” on the lung that is less than 3 cm or 1½ inches in diameter by 
chest X-ray). 
The differential diagnosis of multiple pulmonary nodules is large and includes congenital 
and inherited disorders, malignancy, infectious etiologies, noninfectious granulomatous and 
inflammatory conditions, among many others. Disseminated cysticercosis with pulmonary 
involvement should be suspected in any patient presenting with multiple pulmonary 
nodules who is an immigrant from an endemic region or an individual who has resided in 
one of the countries where cysticercosis is endemic [113].  
Taking into consideration that the only infectious disease causing multiple pulmonary 
nodules and associated cutaneous manifestation are: blastomycosis, coccidiomycosis, 
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tuberculosis and cysticercosis then the differential diagnosis of pulmonary cysticercosis is 
very easy if DCC/NCC complex is present. 
In 1971, Bassermann [114] found some radiographic problems in pulmonary cysticercosis 
because at that time computed tomography system was not available. Siemens Medical 
Solutions (then known as Siemens Medical Engineering) presented the first machine 
commercially available in May 1974. Therefore confirmation of NCC by imagenology was 
not done. Other authors studied patients with pulmonary cysticercosis at different times 
and all of them agree that this is an uncommon condition [115-119]. 
Schotz and Mentis [116] in 1987 reported a 48-years-old black man admitted to hospital with 
a 2-month history of a painless mass on the left side of his neck. He also complained of mild 
attacks of paroxysmal dyspnoea at night and progressive deafness of his left ear. On direct 
questioning the patient referred a few grand mal seizures during the six years before 
admission. No other complaints or previous illnesses of note were elicited. The patient was 
born in Transkei (near to Mthatha in South Africa) and had travelled throughout many parts 
of the country seeking work, which he secured in the gold mines mainly. He ate a variety of 
meats including pork and smoked and drank excessively at times.On examination he 
appeared healthy and was of normal build. The pulse rate was 72/min, blood pressure 
110/60 mmHg and temperature 37,2°C. Numerous subcutaneous nodules, ranging in size 
from 1 cm to 3 cm in diameter, which were well circumscribed and freely movable, could be 
palpated all over the neck, chest and legs. A bigger mass was palpable inferior to the left ear, 
extending down the left side of the neck. There was conduction deafness of the left ear. On 
chest auscultation a few fine crepitations were audible at the bases of both lungs. Computed 
tomography of the brain, neck, thorax and upper abdomen revealed extensive organ 
involvement, including brain, thyroid, lungs, pancreas, kidney, spleen and muscle; and 
biopsies of two of the subcutaneous nodules were histologically pathognomonic of T. solium 
cysticercosis. The patient received praziquantel (Biltricide; Bayer-Miles) 1,75 g twice daily 
and prednisone 20 mg per day for 4 weeks. He was reassessed radiologically after 4 weeks. 
There was marked regression in the size and numbers of nodules in the lung fields. 
Clinically, most of the subcutaneous nodules had disappeared. Authors highlighted that the 
radiological appearance of cysticercosis in the lung cannot be differentiated from other 
parasitic infections, e.g. echinococcosis, pentastomiasis, paragonimiasis and histoplasmosis, 
or conditions such as tuberculosis, alveolar carcinoma and metastases due to the varying 
reaction of the lung tissue and difference in size of the larvae [114]. Pulmonary sparganosis 
should be exluded from the list of differential diagnosis as well [120]. Although rare, 
pulmonary cysticercosis does occur and in developing countries should not be overlooked 
in the differential diagnosis of multiple lung opacities. 
From our knowledge, this is the only patient with renal involvement reported to the medical 
literature ever. 
From one case reported in Korea, authors concluded that the presence of cysticerci are 
difficult to discern from pulmonary infiltrates, because other parasitic infestations or 
tuberculosis, as well as metastatic lesions, produce similar chest X-ray findings and similar 
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clinical symptoms (as before-mentioned) and they suggest open lung biopsy for 
confirmation, for treatment PZQ (50 mg/kg per day for 15 days) and to consider pulmonary 
cysticercosis as a diagnostic possibility in patients with nodular infiltrates in the lungs, 
especially in endemic areas, until such infiltrates are otherwise explained [118].  
In 2011, a radiologist from Punjab, India [119] reported a well documented 28-year-old man 
presented with a history of fever, dry cough, headache and decreased responsiveness over 7 
days. One year previously, he had suffered seizures and was hospitalised in another centre 
with an initial diagnosis of NCC and received treatment for it. MRI at that time depicted 
numerous ring enhancing lesions with eccentric scolex (‘cyst with dot’ appearance) in the 
cerebral hemispheres, subarachnoid space and orbits. The patient had a history of pork 
intake and intravenous drug misuse. Physical examination at the time of admission revealed 
small, movable, painless subcutaneous nodules that were palpable over the arms, axillae 
and trunk. No abnormalities were noted on auscultation of the lungs. Blood and urine 
cultures were negative. Sputum analysis was normal. A chest x-ray revealed small nodules 
in both lungs. This is the first report about pulmonary cysticercosis in a patient presenting 
DCC and subarachnoid NCC.  
Next patient was reported by Strawter et.al., [113] a few weeks ago. They studied a 31-year-
old incarcerated Hispanic male presented with a nonproductive cough for several months 
and one episode of blood tinged sputum. He admitted to weight loss and night sweats, 
headaches, and visual disturbances. He was an immigrant from Honduras and lived in 
Arizona for the past 15 years. He had chronic hepatitis C infection and was receiving 
treatment with pegylated interferon-alfa-2a (IFN-α) and ribavirin. His symptoms began one 
month after initiating antiviral therapy.They confirmed pulmonary nodules with cutaneous 
manifestations and concluded that: Disseminated cysticercosis with pulmonary involvement 
should be suspected in any patient presenting with multiple pulmonary nodules who is an 
immigrant from an endemic region or an individual who has resided in one of the countries 
where cysticercosis is present or when NCC is well documented. Lung are the second 
thoracic organ affected by T solium cysticercosis preceded by the heart (See Figure 14) 
 
 
Figure 14. Thoracic organs involved in disseminated cysticercosis 
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6.3. Cardio-pulmonary cysticercosis 
The heart and the lungs are the thoracic organs more frequently affected by parasitic 
infections. The involvement of the heart may be part of a more generalized illness, as is the 
case with human African trypanosomiasis [102] and other parasitic diseases as before-cited. 
The first case reported under this condition presented a massive cardiopulmonary 
cysticercosis and an associated leukemia. [121] being this one the only patient presenting 
this type of co-morbidity. Bastos et al., [122] from Brazil reported another patient and 
highlighted the importance of imagenology (CT scan) of the chest for confirmation of 
diagnosis based on their findings: multiple pulmonary, cardiac and chest wall nodules 
concluding that cysticercosis should be considered in the differential diagnosis of multiple 
pulmonary nodules, mainly in those patients with similar lesions in the cardiac muscle 
and/or in the chest wall which made the overall diagnosis easy to perform.  
Other important contribution is made by Jain et al., [123]. They reported a 19-year-old boy 
from Mumbai (India) who presented with a history of headache and vomiting for six 
months, seizures for three months, and decreased vision and bilateral proptosis (right more 
than left) for one month. The patient was apparently asymptomatic six months back. The 
patient was a vegetarian. Examination revealed subcutaneous nodules over the right eyelid, 
with mild proptosis of both eyes. Using the Snellen chart, his vision was found to be 6/30 in 
the right eye and 7/30 in the left eye. Neurological examination did not reveal any 
abnormality. All the laboratory investigations were normal. The patient was referred for 
MRI of the brain, which revealed multiple 3–8 mm-sized cystic lesions with T2-hypointense 
foci within both cerebral hemispheres, cerebellum, extraocular muscles of both orbits and 
soft tissues of the neck. Similar lesions were distributed in the muscles and adjacent 
subcutaneous tissues of the back, abdominal wall, thighs, calves, legs, forearms and arms as 
well as the extradural spinal space. Multiple cystic lesions were seen in both lungs and in 
the cardiac muscles. Hyperintense nodules were also seen in the pancreas. For further 
evaluation, a high-resolution CT (HRCT) of the lungs was performed, which revealed 
bilateral multiple, randomly distributed, 3-8 mm nodules. A B-scan USG was performed, 
which revealed a large intravitreal cyst within the right eye, with a tiny hyperechoic scolex. 
The left eye was normal. On superficial probe evaluation of the heart and pericardium 
through a parasternal window, using a high-frequency 7 to 12 MHz linear transducer (HDI 
3000; Philips Medical Systems, Andover, MA, USA), there were multiple oval to circular, 
0.5–1.5-cm sized, predominantly anechoic lesions in the heart muscle. Later, a dedicated 2D 
echocardiography was performed, which revealed multiple disseminated cysticerci 
involving the muscle of the heart. On the basis of these imaging findings, a diagnosis of 
disseminated cysticercosis was made. The patient also had right bundle branch block on 
electrocardiogram; however, other functional parameters such as ejection fraction, valve 
function, systolic function and chamber size were normal on 2D echocardiography. A final 
diagnosis of cysticercosis was made and this was confirmed on muscle biopsy. Because 
drug-induced inflammation due to praziquantel may cause irreversible damage in cases 
with ocular lesions, this medication was not given, and the patient was treated 
symptomatically with antiepileptic drugs, steroids, and diuretics. To the best of our 
knowledge, this is the best documented patient presented with disseminated cysticercosis 
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with cardiac, pulmonary, pancreatic, spinal, extradural, and ocular involvement reported in 
the international medical literature up today and clearly demonstrate the extent to which 
cysticercosis can be disseminated and almost all probable combination of involved organs.  
Although this report does not describe the state of the evolutionary of cysticercus, it is 
logical to assume that a parasitic infection of this magnitud is due to uninterrupted 
ingestion of T. solium eggs which is only possible under deplorable sanitary conditions. Such 
a quantity of larvae of T. solium solium when driving through the bloodstream in a young 
patient allows its dissemination almost uniformly throughout the body including the CNS. 
This aspect will be discussed below. 
6.4. Orbital cysticercosis 
In the next chapter we will refer more details to the ocular cysticercosis according to their 
different locations within and outside of the eyeball but without exceeding the limits of the 
orbital cavity. In this chapter we will review only the clinical features of the ocular 
cysticercosis associated with damage to other organs as part of the disseminate cysticercosis, 
based on the results published in the international medical literature. 
Almost all patients presenting cysticercotic orbital involvement and associated DCC were 
from India as we show below. Cheung et al., [124] in 1987 reported a patient with 
disseminated cysticercosis involving orbit, tongue, parotid glands, epicardial fat tissue, 
muscles, and subcutaneous tissues confirmed by MRI. This was the first communication on 
combination of cysticercosis of the orbit, parotid gland and epicardial fat. Cysticercosis of 
the eyelid was studied by Gupta et al., [125]. One of the youngest patient (5-years-old) ever 
studied was reported by Asrani and Morani [108] their patient apart from 
cardiocysticercosis (before-mentioned) also presented multiple orbital cysts with decreased 
visual acuity and neuropsychiatric manifestations. Despite this ocular involvement this 
patient received anthelmintic agents and not further complications were informed. 
Combination of epilepsy, DCC, proptosis of the eyes, fever and arthralgia can be seen [8]. 
Disseminated cysticercosis can cause intravitreal lesions with exudative retinal detachment 
and bilateral extra ocular muscular damage at the same time [126] or afect only the brain, 
orbits, subcutaneous tissue [127, 128] the eyes, tongue and spinal cord [127] or the tongue, 
eyes, face and scalp muscles [130], and an extensive involvement of both orbits [131]; face, 
scalp muscles, subconjuctival cysts in the eyes and cysticercotic encephalitis [132], 
cardiopulmonary cysticercosis plus proptosis of the eyes, extra ocular muscles of both 
orbits, extradural spinal, and cerebellar involvement [123] and other combinations such as: 
subarachnoid NCC, Brown syndrome, different extra ocular muscles involvement, 
mimicking idiopathic orbital inflammation, retina involvement , and canine tooth syndrome 
have been reported to the medical literature [119, 133-138]. 
6.5. Other organs affected  
As we have seen, the disseminate cysticercosis (muscular and subcutaneous tissue) is 
always associated with the NCC and in addition, it can be associate to heart, lung, eyes, 
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spleen, pancreas, parotid, liver, kidneys and pharynx involvement. Here we will discuss 
about some cases presenting this modalities of DCC. 
Other presentations of the DCC include epilepsy with extensive muscular involvement, 
predominantly [139-144], associated liver damage [145], epilepsy with damage of the soft 
tissues of the scalp plus supra and infratentorial lesions; spinal cord [129] epilepsy and DCC 
with huge muscle involvement [146-148], vocal cord [149], thyroid gland [150], the tongue 
[129,151], spleen and pancreas [46]; or even without neurological symptoms [152] or 
immunocompromised patient [153]. 
Cysticercosis of the pharynx the kidneys have been reported in South Africa only [58, 61], as 
we have mentioned previously that serves to highlight that these two locations must also 
keep in mind when planning to perform clinical investigations for this type of patient. Most 
of isolated damaged organs by CC without dissemination of cysticerci throught the 
subcutaneous tissues are not associated with NCC and when it happen then 
extraparenchymal location can be seen. Because only anecdotic reports to the medical 
literature are available at the present moment (See figure 15) we can not arrive to solid 
conclusions and only advices are suggested. 
 
Figure 15. Graphic representation of number of patients with cysticercosis in different organs as part of 
disseminated cysticercosis with involvement of the central nervous system at different levels. 
India has the highest prevalence of disseminate cysticercosis worldwide (Figure 17). Given 
the fact that cysticercosis is an endemic disease in India and that WB-MRI is now available 
on most modern MRI scanners, especially in academic institutions, Goenka and Kumar [154, 
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155] believe that awareness about this technique may enable to his fellow colleagues to 
explore its valuable potential in disseminated cysticercosis. Most of patients presenting DCC 
are from India (New Delhi) as can be seen in the figure 16 but even there, the number of well 
documented patient is still no enough to design an accurate clinical trial looking for a 
medication of choice for this condition. Based on our experiency, to combine Praziquantel 
and Albendazole with steroids provide good results if there is not involvement of the heart, 
the eyes or massive NCC. 
 
Figure 16. Distribution of disseminated cysticercosis worldwide. 
As noted in the previous map there are two large areas in Latin America and Africa where 
the disease is may be present but the ignored epidemiological conditions of those not having 
established contact with the civilized world make impossible to predict the possible number 
of patients although by photos published in Internet we could not identified anyone. 
7. Mortality rate in disseminated cysticercosis 
The mortality rate for the cysticercosis is widespread and extremely low, in our series was 
always below 0.05 % in the past 15 years. 
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Based on our experience and in the cases reported in the international medical literature the 
causes of death are almost always related to the NCC and anecdotal cases secondary to 
pancreatic or cardiopulmonary complications. 
The most frequent cause of death related to the NCC in patients with CCD is the 
intraventricular NCC with intracranial hypertension by obstructive hydrocephalus, the 
subarachnoid NCC with cerebrovascular complications, the NCC of the insula with associated 
neurogénic heart or sudden unexpected death and the massive NCC. When there are more 
than a thousand cysts in the brain the mortality rate is extremely high (see figure 17). 
 
Figure 17. CT scan of the brain showing massive neurocystciercosis. 
8. Why some cisticercus move to one path while other move to another 
one? 
The cerebellar lesions are an expression of this type of distribution as they generally 
cisticercotic lesions in the posterior fossa are only seen when there are massive infestations 
or when the cysticerci traveling through a non-laminar flow secondary to vascular lesions 
not described in the medical literature (See figure 18). 
We think this situation happen because of the haemodynamic characteristic of the blood 
flow can change in different blood vessel. Let us to explain what probably happen when 
cysticerci coincide in the same place at the same time. When between two cysticercus in 
movement speed gradient exists, or is that a moves faster than the other, they develop 
friccian forces acting tangentially to the same. The friction forces are trying to introduce 
rotation between the cysticerci in motion, but simultaneously the viscosity seeks to prevent 
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rotation. Depending on the relative value of these forces can be produce different flow 
states. When the gradient of speed is low, the inertia force is greater than the friction, the 
cysticerci move but do not rotate, or they make it but with very little power, the final result 
is a movement in which the particles follow paths defined, and all of the particles that pass 
by a point in the field of flow follow the same trajectory. This type of flow was identified by 
O. Reynolds and is called "laminar", meaning that the particles are moving in the form of 
layers or sheets. The increase of velocity gradient increases the friction between neighboring 
cysticercus to the fluid, and these become a significant energy of rotation, the viscosity loses 
its effect, and due to the rotation of the cysticercus change trajectory. Going from one path to 
another, the cysticerci collide and change course in erratic. This type of flow is called 
"turbulent". Turbulent flow can also be due to abnormalities in the wall of blood vessels.The 
turbulent flow is characterized by:  
 The cysticercus in the fluid does not move along with defined trajectories.  
 The action of the viscosity is negligible.  
 The cysticerci in the fluid possess appreciable energy of rotation, and they move 
erratically colliding with each other.  
When entering the fluid articles to layers of different speed, its linear time increases or 
decreases, and the particles of the neighboring does so in a manner that is contrary. When 
the forces of inertia of the fluid in movement are very low, the viscosity is the dominant 
force and the flow is laminar. When dominated by the forces of inertia the flow is turbulent.  
 
 
Figure 18. Massive neurocysticercosis showing very few active cerebellar lesions. 
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9. Conclusion 
The disseminated cysticercosis is a rare disease and the largest number of cases have been 
confirmed and published in India. Disseminated cysticercosis is accompanied by 
neurocysticercosis especially in its intraparenchymal localization but other locations are 
possible. There have been no reported cases of neurocysticercosis intraventricular associated 
to disseminated cysticercosis. 
Apart from the subcutaneous tissue, muscles and the brain, the organ most frequently 
affected is the heart and the disorder of cardiac conduction is the main problem. Orbital 
cysticercosis (intra or extra ocular) is not associated with the disseminated cysticercosis in 
South Africa while in India makes it with more frequency. 
At the present time, DCC seems to be not associated to HIV infections. 
The low prevalence of the disseminated cysticercosis does not mean that cysticercosis is 
about to disappear in the near future. 
It is possible that the defining characteristics of blood flow may be determined by the erratic 
locations of cysticerci, but well designed hemodynamic studies are needed to demonstrate 
this hypothesis. 
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